*Refresh the page if the below document does not appear.
The drugmaker Eli Lilly announced that its drug ‘Ramiven’ which is already approved for the treatment of certain types of HR+ HER2- advanced or metastatic breast cancer has added indication following approval from the (DCGI) Drug Controller General of India.
The Indian drug major Cipla announced on Thursday that USFDA designated its Goa manufacturing unit as OAI (Official Action Indicated) which will impact the product approvals to be marketed in the US.
Pharma stocks experienced a return in 2020 following the COVID-19 outbreak but the performance has been declining recently. Sun Pharma, Cipla, and Syngene are a few in the top 10 list of pharma and healthcare stocks that have been added by active fund managers lately.
The Maharashtra Government issued an order to recall Emcure Pharma’s Orofer FCM injection indicated for the treatment of Iron Deficiency Anemia after the death of a patient due to suspected ADR (Adverse Drug Reaction) following the administration of the drug.
Orchid Pharma was acquired by Dhanuka Laboratories under insolvency resolution back in March 2020. According to a senior executive, the drugmaker is observing a turn-around in revenue and has increased its profits with the commercialization of a molecule developed inhouse.
On Monday, the Delhi High Court issued a fine of ₹10 lakh for the concealment of facts on Sun Pharma about a trademark infringement case, mentioning that not only does such a practice has to be deprecated but it also has to be penalized.
At the second edition of the Economic Times Healthcare Leaders Summit 2022 leaders of the pharmaceutical industry discussed about various aspects of technological advancements and its positive impact in pharma and healthcare.
If you don’t already have an account click the button below to create your account.Create New Account